Vanguard Group Inc Candel Therapeutics, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,007,112 shares of CADL stock, worth $9.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,007,112

Previous 1,787,549 12.28%

Holding current value

$9.25 Million

Previous $9.04 Million 14.06%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$4.79 - $7.0 $1.05 Million - $1.54 Million	219,563 Added 12.28%	2,007,112 $10.3 Million
Q2 2025 Aug 11, 2025	BUY	$4.39 - $6.04 $225,843 - $310,727	51,445 Added 2.96%	1,787,549 $9.04 Million
Q1 2025 May 09, 2025	BUY	$5.65 - $12.21 $2.24 Million - $4.85 Million	396,954 Added 29.64%	1,736,104 $9.81 Million
Q4 2024 Feb 11, 2025	BUY	$3.96 - $9.96 $1.56 Million - $3.91 Million	392,885 Added 41.52%	1,339,150 $11.6 Million
Q3 2024 Nov 13, 2024	BUY	$5.02 - $7.76 $641,129 - $991,068	127,715 Added 15.6%	946,265 $6.56 Million
Q2 2024 Aug 13, 2024	BUY	$1.68 - $14.0 $465,788 - $3.88 Million	277,255 Added 51.22%	818,550 $5.08 Million
Q1 2024 May 10, 2024	BUY	$1.21 - $1.86 $139,810 - $214,915	115,546 Added 27.14%	541,295 $855,000
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.47 $14,742 - $31,869	21,680 Added 5.37%	425,749 $625,000
Q3 2023 Nov 14, 2023	SELL	$0.91 - $1.3 $1,534 - $2,191	-1,686 Reduced 0.42%	404,069 $371,000
Q4 2022 Feb 10, 2023	BUY	$1.48 - $3.2 $435 - $940	294 Added 0.07%	405,755 $726,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $5.56 $5,305 - $9,424	-1,695 Reduced 0.42%	405,461 $1.31 Million
Q1 2022 May 13, 2022	SELL	$3.66 - $8.0 $30,001 - $65,576	-8,197 Reduced 1.97%	407,156 $2.07 Million
Q4 2021 Feb 14, 2022	BUY	$6.34 - $11.9 $1.28 Million - $2.4 Million	201,773 Added 94.47%	415,353 $3.25 Million
Q3 2021 Nov 12, 2021	BUY	$5.75 - $11.21 $1.23 Million - $2.39 Million	213,580 New	213,580 $2.32 Million

Others Institutions Holding CADL

# of Institutions

Shares Held

14.9M

Call Options Held

313K

Put Options Held

127K

View Full List

About Candel Therapeutics, Inc.

Ticker CADL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,891,900
Market Cap $133M
Description
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...

More about CADL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Candel Therapeutics, Inc. Transaction History